Literature DB >> 30425064

The Familiality of Rapid Renal Decline in Diabetes.

Scott G Frodsham1, Zhe Yu2, Ann M Lyons3, Adhish Agarwal1, Melissa H Pezzolesi1, Li Dong4, Titte R Srinivas4, Jian Ying5, Tom Greene5, Kalani L Raphael1,6, Ken R Smith2, Marcus G Pezzolesi7,8.   

Abstract

Sustained and rapid loss of glomerular filtration rate (GFR) is the predominant clinical feature of diabetic kidney disease and a requisite for the development of end-stage renal disease. Although GFR trajectories have been studied in several cohorts with diabetes and without diabetes, whether rapid renal decline clusters in families with diabetes has not been examined. To determine this, we estimated GFR (eGFR) from serum creatinine measurements obtained from 15,612 patients with diabetes at the University of Utah Health Sciences Center and established their renal function trajectories. Patients with rapid renal decline (eGFR slope < -5 mL/min/1.73 m2/year) were then mapped to pedigrees using extensive genealogical records from the Utah Population Database to identify high-risk rapid renal decline pedigrees. We identified 2,127 (13.6%) rapid decliners with a median eGFR slope of -8.0 mL/min/1.73 m2/year and 51 high-risk pedigrees (ranging in size from 1,450 to 24,501 members) with excess clustering of rapid renal decline. Familial analysis showed that rapid renal decline aggregates in these families and is associated with its increased risk among first-degree relatives. Further study of these families is necessary to understand the magnitude of the influence of shared familial factors, including environmental and genetic factors, on rapid renal decline in diabetes.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30425064      PMCID: PMC6341306          DOI: 10.2337/db18-0838

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  47 in total

1.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

Authors:  E R Seaquist; F C Goetz; S Rich; J Barbosa
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

2.  Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  D J Pettitt; M F Saad; P H Bennett; R G Nelson; W C Knowler
Journal:  Diabetologia       Date:  1990-07       Impact factor: 10.122

3.  Genetic distances between the Utah Mormons and related populations.

Authors:  T McLellan; L B Jorde; M H Skolnick
Journal:  Am J Hum Genet       Date:  1984-07       Impact factor: 11.025

4.  Risk for ESRD in type 1 diabetes remains high despite renoprotection.

Authors:  Elizabeth T Rosolowsky; Jan Skupien; Adam M Smiles; Monika Niewczas; Bijan Roshan; Robert Stanton; John H Eckfeldt; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2011-02-25       Impact factor: 10.121

5.  Heritability of albumin excretion rate in families of patients with Type II diabetes.

Authors:  C M Forsblom; T Kanninen; M Lehtovirta; C Saloranta; L C Groop
Journal:  Diabetologia       Date:  1999-11       Impact factor: 10.122

6.  Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients.

Authors:  L H Canani; F Gerchman; J L Gross
Journal:  Diabetes       Date:  1999-04       Impact factor: 9.461

7.  Population-based assessment of familial clustering of diabetic nephropathy in type 1 diabetes.

Authors:  Valma Harjutsalo; Shuichi Katoh; Cinzia Sarti; Naoko Tajima; Jaakko Tuomilehto
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

8.  Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus.

Authors:  Carl D Langefeld; Stephanie R Beck; Donald W Bowden; Stephen S Rich; Lynne E Wagenknecht; Barry I Freedman
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

9.  New susceptibility loci associated with kidney disease in type 1 diabetes.

Authors:  Niina Sandholm; Rany M Salem; Amy Jayne McKnight; Eoin P Brennan; Carol Forsblom; Tamara Isakova; Gareth J McKay; Winfred W Williams; Denise M Sadlier; Ville-Petteri Mäkinen; Elizabeth J Swan; Cameron Palmer; Andrew P Boright; Emma Ahlqvist; Harshal A Deshmukh; Benjamin J Keller; Huateng Huang; Aila J Ahola; Emma Fagerholm; Daniel Gordin; Valma Harjutsalo; Bing He; Outi Heikkilä; Kustaa Hietala; Janne Kytö; Päivi Lahermo; Markku Lehto; Raija Lithovius; Anne-May Osterholm; Maija Parkkonen; Janne Pitkäniemi; Milla Rosengård-Bärlund; Markku Saraheimo; Cinzia Sarti; Jenny Söderlund; Aino Soro-Paavonen; Anna Syreeni; Lena M Thorn; Heikki Tikkanen; Nina Tolonen; Karl Tryggvason; Jaakko Tuomilehto; Johan Wadén; Geoffrey V Gill; Sarah Prior; Candace Guiducci; Daniel B Mirel; Andrew Taylor; S Mohsen Hosseini; Hans-Henrik Parving; Peter Rossing; Lise Tarnow; Claes Ladenvall; François Alhenc-Gelas; Pierre Lefebvre; Vincent Rigalleau; Ronan Roussel; David-Alexandre Tregouet; Anna Maestroni; Silvia Maestroni; Henrik Falhammar; Tianwei Gu; Anna Möllsten; Danut Cimponeriu; Mihai Ioana; Maria Mota; Eugen Mota; Cristian Serafinceanu; Monica Stavarachi; Robert L Hanson; Robert G Nelson; Matthias Kretzler; Helen M Colhoun; Nicolae Mircea Panduru; Harvest F Gu; Kerstin Brismar; Gianpaolo Zerbini; Samy Hadjadj; Michel Marre; Leif Groop; Maria Lajer; Shelley B Bull; Daryl Waggott; Andrew D Paterson; David A Savage; Stephen C Bain; Finian Martin; Joel N Hirschhorn; Catherine Godson; Jose C Florez; Per-Henrik Groop; Alexander P Maxwell
Journal:  PLoS Genet       Date:  2012-09-20       Impact factor: 5.917

10.  Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease.

Authors:  Monika A Niewczas; Anna V Mathew; Stephanie Croall; Jaeman Byun; Melissa Major; Venkatta S Sabisetti; Adam Smiles; Joseph V Bonventre; Subramaniam Pennathur; Andrzej S Krolewski
Journal:  Diabetes Care       Date:  2017-01-13       Impact factor: 19.112

View more
  3 in total

1.  Type 1 Diabetes incidence among youth in Utah: A geographical analysis.

Authors:  Matthew L McCullough; Neng Wan; Marcus G Pezzolesi; Timothy W Collins; Sara Elizbeth Grineski; Yehua Dennis Wei; Jose Lazaro-Guevara; Scott G Frodsham; James A Vanderslice; John R Holmen; Titte R Srinivas; Scott A Clements
Journal:  Soc Sci Med       Date:  2021-04-19       Impact factor: 5.379

2.  Implications of a Family History of Diabetes and Rapid eGFR Decline in Patients With Type 2 Diabetes and Biopsy-Proven Diabetic Kidney Disease.

Authors:  Yiting Wang; Lijun Zhao; Junlin Zhang; Yucheng Wu; Rui Zhang; Hanyu Li; Ruikun Guo; Qianqian Han; Tingli Wang; Lin Li; Shanshan Wang; Fang Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-13       Impact factor: 5.555

3.  Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes.

Authors:  Josyf C Mychaleckyj; Erkka Valo; Takaharu Ichimura; Tarunveer S Ahluwalia; Christian Dina; Rachel G Miller; Ivan G Shabalin; Beata Gyorgy; JingJing Cao; Suna Onengut-Gumuscu; Eiichiro Satake; Adam M Smiles; Jani K Haukka; David-Alexandre Tregouet; Tina Costacou; Kristina O'Neil; Andrew D Paterson; Carol Forsblom; Hillary A Keenan; Marcus G Pezzolesi; Marlon Pragnell; Andrzej Galecki; Stephen S Rich; Niina Sandholm; Ronald Klein; Barbara E Klein; Katalin Susztak; Trevor J Orchard; Ron Korstanje; George L King; Samy Hadjadj; Peter Rossing; Joseph V Bonventre; Per-Henrik Groop; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2021-07-14       Impact factor: 14.978

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.